“Fetal exposure to commonly used SRI drugs may affect brain activity in newborns, new research shows. The researchers suggest that the effects of drugs on fetal brain function should be assessed more carefully.”
Mari Videman, Anton Tokariev, Heini Saikkonen, Susanna Stjerna, Hannu Heiskala, Outi Mantere, Sampsa Vanhatalo. Newborn Brain Function Is Affected by Fetal Exposure to Maternal Serotonin Reuptake Inhibitors. Cerebral Cortex, 2016; bhw153 DOI: 10.1093/cercor/bhw153